Influence of Supplementary Vitamin D on Bone Mineral Density When Used in Combination with Selective Estrogen Receptor Modulators
- PMID: 31497579
- PMCID: PMC6718647
- DOI: 10.6118/jmm.19193
Influence of Supplementary Vitamin D on Bone Mineral Density When Used in Combination with Selective Estrogen Receptor Modulators
Abstract
Objectives: Vitamin D is regarded as one of the major nutrients that significantly influence bone metabolism. This study aims to look at the effect of supplementary vitamin D on bone mineral density (BMD) in female osteoporosis patients.
Methods: The retrospective hospital record review was performed on 282 patients who were diagnosed with osteoporosis and treated with selective estrogen receptor modulators (SERMs) between January 2015 and December 2016. Of these patients, 151 were treated with SERMs only while 131 were treated using both SERMs and vitamin D supplements. The BMD and any occurrence of osteoporotic fracture episode were investigated after one year. The result of two groups was compared to find the significance of vitamin D.
Results: Overall, improvement in BMD score was observed in 76% of the patients. The BMD of the SERMs only group improved by 3% in spine and 1% in the hip while that of the SERMs with vitamin D group improved by 6% and 1% respectively. Statistical significance was noticed in the spine only. One distal radius fracture and one single level vertebral fracture occurred in patients of SERMs group while two distal radius fractures occurred in SERMs with vitamin D group. There was no occurrence of around hip fracture in both groups.
Conclusion: The result of the current study suggests that additional vitamin D may have some additive effect on improving BMD of the spine. Further study with the larger study population and the extended study period is recommended.
Keywords: Bone density; Osteoporosis; Selective estrogen receptor modulators; Vitamin D.
Conflict of interest statement
CONFLICT OF INTEREST: No potential conflict of interest relevant to this article was reported.
Figures
Similar articles
-
The Efficacy of Selective Estrogen Receptor Modulators Monotherapies in Postmenopausal Women with Osteopenia.J Bone Metab. 2022 Aug;29(3):185-189. doi: 10.11005/jbm.2022.29.3.185. Epub 2022 Aug 31. J Bone Metab. 2022. PMID: 36153854 Free PMC article.
-
Selective estrogen receptor modulators (SERMs) with vitamin D composite agent can prevent fracture better than SERMs treatment: based on the National Health Claims Database 2017-2019.Osteoporos Int. 2024 May;35(5):775-783. doi: 10.1007/s00198-024-07022-7. Epub 2024 Jan 19. Osteoporos Int. 2024. PMID: 38240755
-
Preoperative bone health assessment and optimization in spine surgery.Neurosurg Focus. 2020 Aug;49(2):E2. doi: 10.3171/2020.5.FOCUS20255. Neurosurg Focus. 2020. PMID: 32738805
-
Osteoporosis: a review and its dental implications.Compend Contin Educ Dent. 2002 Nov;23(11):1001-4, 1006, 1008 passim; quiz 1014. Compend Contin Educ Dent. 2002. PMID: 12526189 Review.
-
[Large clinical trials for osteoporosis].Therapie. 2003 Sep-Oct;58(5):415-20. doi: 10.2515/therapie:2003067. Therapie. 2003. PMID: 14682189 Review. French.
Cited by
-
The Efficacy of Selective Estrogen Receptor Modulators Monotherapies in Postmenopausal Women with Osteopenia.J Bone Metab. 2022 Aug;29(3):185-189. doi: 10.11005/jbm.2022.29.3.185. Epub 2022 Aug 31. J Bone Metab. 2022. PMID: 36153854 Free PMC article.
-
Modulation of the vitamin D/vitamin D receptor system in osteoporosis pathogenesis: insights and therapeutic approaches.J Orthop Surg Res. 2023 Nov 13;18(1):860. doi: 10.1186/s13018-023-04320-4. J Orthop Surg Res. 2023. PMID: 37957749 Free PMC article. Review.
-
Selective estrogen receptor modulators (SERMs) with vitamin D composite agent can prevent fracture better than SERMs treatment: based on the National Health Claims Database 2017-2019.Osteoporos Int. 2024 May;35(5):775-783. doi: 10.1007/s00198-024-07022-7. Epub 2024 Jan 19. Osteoporos Int. 2024. PMID: 38240755
-
A randomized controlled trial of the effect of raloxifene plus cholecalciferol versus cholecalciferol alone on bone mineral density in postmenopausal women with osteopenia.JBMR Plus. 2024 May 30;8(7):ziae073. doi: 10.1093/jbmrpl/ziae073. eCollection 2024 Jul. JBMR Plus. 2024. PMID: 38939828 Free PMC article. Clinical Trial.
References
-
- NIH consensus development panel on osteoporosis prevention, diagnosis, and therapy, March 7-29, 2000: highlights of the conference. South Med J. 2001;94:569–573. - PubMed
-
- Astrand J, Thorngren KG, Tägil M, Akesson K. 3-year follow-up of 215 fracture patients from a prospective and consecutive osteoporosis screening program. Fracture patients care! Acta Orthop. 2008;79:404–409. - PubMed
-
- Centre for Metabolic Bone Diseases, University of Sheffield. Fracture Risk Assessment Tool (FRAX®) Sheffield: University of Sheffield; [cited 2018 Nov 25]. Available from: https://www.sheffield.ac.uk/FRAX/
-
- Schneider EL, Guralnik JM. The aging of America. Impact on health care costs. JAMA. 1990;263:2335–2340. - PubMed
LinkOut - more resources
Full Text Sources